Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Mindpeak logo — Our mission is to enable personalised cancer treatment throu...

Mindpeak

Our mission is to enable personalised cancer treatment through AI tissue diagnostics

Founded 2018 Germany Hamburg, Germany 49 employees Series A Total: $19.67M AI, Biotechnology +2

General Information

Company Name Mindpeak
Founded Year 2018
Location Germany Hamburg, Germany +1
Employees 49
Industries AI, Biotechnology, Health Care +1
Funding Stage Series A
Social

Get notified when Mindpeak moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Mindpeak

Mindpeak, founded in 2018 and headquartered in Germany, is revolutionizing personalized cancer treatment through AI tissue diagnostics. The company partners with leading pathology and university labs to alleviate the growing workload on cancer specialists by offering cutting-edge automation tools powered by artificial intelligence and deep learning.

Their innovative technology facilitates reliable and reproducible visual diagnoses, allowing experts to concentrate on critical tasks necessitating human expertise, rather than repetitive ones like cell or biomarker quantification.

The company operates across industries including AI, Biotechnology, Health Care, and Machine Learning. Recently, Mindpeak secured a $15.30M Series A investment on 01 October 2024 from an impressive roster of investors such as Apex Ventures, NovaCapital, EIC Fund, and ZEISS Medical Technology.

Taxonomy: AI tissue diagnostics, personalized cancer treatment, medical image analysis, automation tools, visual diagnosis, deep learning, cancer diagnostics, pathology, biomarker quantification, cell quantification, cancer specialists support, diagnostic reliability, diagnostic reproducibility

Services & Products

AI-driven Biomarker Discovery
Clinical Trial Support
Pathology Integration
Next-Gen Biomarkers Deployment
Tissue Computation

Target Customers

Pharmaceutical Companies Diagnostic Laboratories Biopharma Researchers Oncology Departments

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 16
Investor Investor Investor Investor Investor Investor Investor
•••• •••• 		01 Oct 2024
Early VC •••••• 7
Investor Investor Investor Investor Investor Investor
•••• •••• 		01 Feb 2024
Grant •••••• 1
Investor
01 Mar 2020
Seed •••••• 5
Investor Investor Investor Investor
•••• •••• 		01 Oct 2019

Latest News

View All
Hamburg's Mindpeak using AI to diagnose cancer — Hamburg-business.com
Hamburg's Mindpeak using AI to diagnose cancer
Hamburg-business.com Sep 08, 2021
Crosscope strikes Partnership with Mindpeak to improve Cancer Diagnosis with Digital Pathology Image... — Business-standard.com
Crosscope strikes Partnership with Mindpeak to improve Cancer Diagnosis with Digital Pathology Image Analysis
Business-standard.com Feb 28, 2022
UKE erhält 1,2 Millionen Euro für strahlenbiologische Forschung — Hamburg-business.com
UKE erhält 1,2 Millionen Euro für strahlenbiologische Forschung
Hamburg-business.com May 21, 2024
Mindpeak Announces Collaboration With Roche to Enhance Cancer Diagnostics Through AI — Biospace.com
Mindpeak Announces Collaboration With Roche to Enhance Cancer Diagnostics Through AI
Biospace.com Sep 16, 2024
Mindpeak secures $15.3M in series A funding to accelerate growth in AI-based digital pathology — Businesswire.com
Mindpeak secures $15.3M in series A funding to accelerate growth in AI-based digital pathology
Businesswire.com Sep 30, 2024
Yapay zeka destekli sağlık girişimi Mindpeak, 15.3 milyon dolar yatırım aldı — Webrazzi
Yapay zeka destekli sağlık girişimi Mindpeak, 15.3 milyon dolar yatırım aldı
Webrazzi Oct 01, 2024

Mindpeak Alternatives & Competitors

View All Alternatives
Mindpeak vs
IMcoMET
IMcoMET The Netherlands

Access a new source of biomarkers

4 employees
Biopharma, Biotechnology
Mindpeak vs
Veracyte, Inc.
Veracyte, Inc. United States

Cancer Genomic Testing & Molecular Diagnostics | Veracyte Inc.

IPO
748 employees
Biotechnology, Health Care
Compare Mindpeak vs Veracyte, Inc.
Mindpeak vs
SDS Optic Inc.
SDS Optic Inc. Poland

Lifesaving Innovations with a vision to help increase cancer survival by 30% by 2030 and co-create t...

Seed
27 employees
Biotechnology, Medical Devices
Compare Mindpeak vs SDS Optic Inc.
Also compare with: Mindpeak vs LungLife AI LungLife AI View all alternatives

FAQ About Mindpeak

Our mission is to enable personalised cancer treatment through AI tissue diagnostics
Mindpeak was founded in 2018.
Mindpeak is headquartered in Hamburg, Germany.
Mindpeak operates in the following industries: AI, Biotechnology, Health Care, Machine Learning.
Mindpeak has approximately 49 employees.
Mindpeak has completed 4 funding rounds, raising a total of $19.67M. The latest funding stage is Series A.
Mindpeak offers: AI-driven Biomarker Discovery, Clinical Trial Support, Pathology Integration, Next-Gen Biomarkers Deployment, Tissue Computation.
Top alternatives and competitors to Mindpeak include IMcoMET, Veracyte, Inc., SDS Optic Inc., LungLife AI, Tennessee Oncology. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Mindpeak and IMcoMET are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Mindpeak and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy